drops glp-1 RA Adherence Shows Drop-Off After 1 Year GLP-1 Drops for Women and
Description
Novo was first in the market,got CMS Medicare approval with Narrow Pipeline of Drugs only on Weight loss & Diabetes (Front runner Semaglutide) Lilly has better Efficacy Drug(Tirzepatide & Pipeline drugs) for Wt loss/Diabetes,Longer IP Patent Runway till mid 2030s with better Growth Penetration With Wider Pipeline of Pharma drugs including Oncology/ Neurology/ Immunology/ Inflammation,Urology- Erectile Dysfunction,Osteoporosis in Men and Women and afford to run the price war with Novo and wipeout their Business Eli Lilly is winning hands down
When reconstituted with bacteriostatic water and stored refrigerated at 2 to 8 degrees Celsius, tirzepatide maintains its potency for approximately 28 days
Graphic created with gemini.google.com
From there, protein support and electrolytes are commonly added as part of a more balanced routine
It covers the highest doses used in GLP-1 therapy
Although the study primarily reports clinical outcomes, changes in specific biomarkers indirectly suggest potential mechanisms of action of GLP-1RAs
